Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CB-010 by Caribou Biosciences for Follicular Lymphoma: Likelihood of Approval
CB-010 is under clinical development by Caribou Biosciences and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
Data Insights
CB-010 by Caribou Biosciences for Mantle Cell Lymphoma: Likelihood of Approval
CB-010 is under clinical development by Caribou Biosciences and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData,...